France· FR:65617572
MIOREL 4 mg, gélule
A thiocolchicoside product containing thiocolchicoside, registered in France by FARMACEUTICO SIT. The same ATC class is registered in 3 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Thiocolchicoside is registered in 3 of 19 countries.
Countries holding a registration under ATC M03BX05 (thiocolchicoside), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 3 of them publish a price we can compare per daily dose
Thiocolchicoside · ATC M03BX05
3 / 19 countries
- Czechiaprice
- Franceprice
- Polandprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- THIOCOLCHICOSIDE
- Manufacturer
- FARMACEUTICO SIT
- Country
- France (FR)
- ATC code
- M03BX05
- ATC class
- Thiocolchicoside
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip133400933398743plaquette(s) PVC-Aluminium de 12 gélule(s)
- cip133400933398804plaquette(s) PVC-Aluminium de 24 gélule(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Thiocolchicoside in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Bulgaria · Tiyozid, Мускомед
- Cyprus · Relief
- Czechia · Muscoril
- Greece · Haliver, Relief
- Italy · Decontril, Miorexil
- Poland · Tiocolis
- Portugal · Coltramyl, Relmus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7347d043-3502-4b12-b2bf-915faa073b96 GET /v1/drugs/7347d043-3502-4b12-b2bf-915faa073b96?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65617572",
"date_amm": "1991-07-01",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "THIOCOLCHICOSIDE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about thiocolchicoside.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.